Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-21

Clinical Trial Update: Safety, Efficacy and Acceptability of Flavocoxid (Limbrel)A Pilot Study [NA]

View source ↗

Summary

This completed pilot trial evaluated the safety, efficacy and acceptability of flavocoxid (Limbrel) for osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Limbrel (flavocoxid)

Snippet

Sponsor: Primus Pharmaceuticals | Conditions: Osteoarthritis | NA | Status: COMPLETED